These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27809606)

  • 1. Design, synthesis and antibreast cancer MCF-7 cells biological evaluation of heterocyclic analogs of resveratrol.
    Du C; Dong MH; Ren YJ; Jin L; Xu C
    J Asian Nat Prod Res; 2017 Sep; 19(9):890-902. PubMed ID: 27809606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti-tumor agents.
    Yao RS; Lu XQ; Guan QX; Zheng L; Lu X; Ruan BF
    Eur J Med Chem; 2013 Apr; 62():222-31. PubMed ID: 23353741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of biaryl aryl stilbenes/ethylenes as antimicrotubule agents.
    Kumar AS; Reddy MA; Jain N; Kishor C; Murthy TR; Ramesh D; Supriya B; Addlagatta A; Kalivendi SV; Sreedhar B
    Eur J Med Chem; 2013 Feb; 60():305-24. PubMed ID: 23313639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
    Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
    Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents.
    Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
    Eur J Med Chem; 2014 Oct; 86():211-8. PubMed ID: 25164760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds.
    Abdelhafez OM; Ahmed EY; Abdel Latif NA; Arafa RK; Abd Elmageed ZY; Ali HI
    Bioorg Med Chem; 2019 Apr; 27(7):1308-1319. PubMed ID: 30792101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents.
    Ruan BF; Lu X; Li TT; Tang JF; Wei Y; Wang XL; Zheng SL; Yao RS; Zhu HL
    Bioorg Med Chem; 2012 Jan; 20(2):1113-21. PubMed ID: 22189271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heteroaromatic analogs of the resveratrol analog DMU-212 as potent anti-cancer agents.
    Penthala NR; Thakkar S; Crooks PA
    Bioorg Med Chem Lett; 2015 Jul; 25(14):2763-7. PubMed ID: 26022840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
    Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
    Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cytotoxic evaluation of a series of resveratrol derivatives modified in C2 position.
    Huang XF; Ruan BF; Wang XT; Xu C; Ge HM; Zhu HL; Tan RX
    Eur J Med Chem; 2007 Feb; 42(2):263-7. PubMed ID: 17000031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cytotoxic activity evaluation of 2,3-thiazolidin-4-one derivatives on human breast cancer cell lines.
    Sala M; Chimento A; Saturnino C; Gomez-Monterrey IM; Musella S; Bertamino A; Milite C; Sinicropi MS; Caruso A; Sirianni R; Tortorella P; Novellino E; Campiglia P; Pezzi V
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4990-5. PubMed ID: 23860590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation.
    Naret T; Bignon J; Bernadat G; Benchekroun M; Levaique H; Lenoir C; Dubois J; Pruvost A; Saller F; Borgel D; Manoury B; Leblais V; Darrigrand R; Apcher S; Brion JD; Schmitt E; Leroux FR; Alami M; Hamze A
    Eur J Med Chem; 2018 Jan; 143():473-490. PubMed ID: 29202409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker.
    Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y
    Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and anti-breast cancer evaluation of new triarylethylene analogs bearing short alkyl- and polar amino-/amido-ethyl chains.
    Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1963-9. PubMed ID: 26972118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of (Z)-2,3-diphenylacrylonitrile analogs as anti-cancer and anti-microbial agents.
    Alam MS; Nam YJ; Lee DU
    Eur J Med Chem; 2013 Nov; 69():790-7. PubMed ID: 24113364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells.
    Minutolo F; Sala G; Bagnacani A; Bertini S; Carboni I; Placanica G; Prota G; Rapposelli S; Sacchi N; Macchia M; Ghidoni R
    J Med Chem; 2005 Nov; 48(22):6783-6. PubMed ID: 16250636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity.
    Naini R; Ravikumar E; Singh SS; Kancha RK; Rao KV; Reddy VD
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1537-1544. PubMed ID: 28356012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 1,1,2-triphenylethylenes and their antiproliferative effect on human cancer cell lines.
    Zheng L; Wei Q; Zhou B; Yang L; Liu ZL
    Anticancer Drugs; 2007 Oct; 18(9):1039-44. PubMed ID: 17704654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinazoline Based HSP90 Inhibitors: Synthesis, Modeling Study and ADME Calculations Towards Breast Cancer Targeting.
    El-Shafey HW; Gomaa RM; El-Messery SM; Goda FE
    Bioorg Med Chem Lett; 2020 Aug; 30(15):127281. PubMed ID: 32527460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
    Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.